Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Recruiting now

Conditions studied: Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

In brief

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Key facts

Study ID

NCT05046080

Run by

M.D. Anderson Cancer Center

People needed

70

Starts

2021-08-06

Expected to finish

2026-09-29

Last updated by the study team

2026-08-10

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with clear cell carcinoma of the cervix at MDACC

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.